1
(100) [M-N2-C6H5N]+·, 106 (25) [M-N2-C6H5N-CH3]+·, 103 (10) [M-N2-C7H7NO]+·. H NMR spectrum
l
l
(acetone-d6), δ, ppm: 2.88 (3H, s, CH3O); 7.45 (2H, d, 2-, 6-HAr ); 7.55-8.10 (5H, m, Ph); 8.20 (2H, d, 3-, 5-HAr ).
2-Phenyl-5-(4-pyridyl)tetrazole (6m). Yield 72%; mp 146°C. UV spectrum (EtOH), λmax (log ε):
270 nm (4.41). Mass spectrum, m/z (I, %): 224 (1) [M+H]+·, 223 (<1) [M]+·, 195 (20) [M-N2]+·, 104 (5)
1
[M-N2-C6H5N]+·, 91 (100) [M-N2-C6H4N2]+·, 64 (40) [M-N2-C6H4N2-HCN]+·. H NMR spectrum (DMSO-d6),
δ, ppm: 7.30-7.90 (5H, m, Ph); 7.60 (2H, d, 4-Py); 8.10 (2H, d, 4-Py).
Fulleropyrazolines (5a-i) (General Method). A solution of hydrazonoyl halide 3 (0.21 mmol) in
bromobenzene (10 ml) was added with stirring during 1.5 h to a solution of fullerene C60 (50 mg, 0.07 mmol)
and triethylamine (50 µl) in bromobenzene (20 ml) at 120-130°C. The mixture was stirred at this temperature for
a further 2 h, the solvent was distilled off, and the residue treated with methanol. The resulting solid was filtered
off, and washed several times with methanol. The adduct was isolated from the mixture obtained by column
chromatography. Eluents were benzene–hexane, 1:1 (for adducts 5a-c), benzene–hexane, 1:3 (for compounds
5d-f), and benzene–hexane 1:10 (for adducts 5g-i).
Fulleropyrazolines (5j-m) (General Method). A solution of fullerene C60 (50 mg, 0.07 mmol) and
tetrazole 6 (0.2 mmol) in bromobenzene was boiled for 3 h. The mixture was then treated analogously to the
previous procedure. Eluents were benzene–hexane, 1:3 (for adducts 5j,k,m), and benzene–ethyl acetate, 10:1
(for 5l).
1
3-(p-Nitrophenyl)-1-phenylpyrazolo[4',5':1,2]fullerene[60] (5a). H NMR spectrum, δ, ppm (J, Hz):
7.47 (3H, m, 3-, 4-, 5-HPh); 7.93 (2H, d, 2-, 6-HPh); 8.30 (2H, d, J = 9.1, 2-, 6-Hp-NO C H ); 8.60 (2H, d, J = 9.1, 3-,
2
6 4
5-Hp-NO C H ). MALDI mass spectrum: [M]-· 959.7.
2
6 4
1
1-(p-Nitrophenyl)-3-phenylpyrazolo[4',5':1,2]fullerene[60] (5b). H NMR spectrum, δ, ppm: 7.54
(3H, m, 3-, 4-, 5-HPh); 8.25 (6H, m, 2-, 3-, 5-, 6-Hp-NO C H ; 2-, 6-HPh). C NMR spectrum, δ, ppm: 75 (Csp3);
13
2
6 4
106 (Csp3); 129, 135, 138.5, 139, 140, 141, 145.5, 146.5, 149, 151.4, 152, 152.5, 152.6, 153, 153.8, 154, 154.5,
155, 155.2, 155.5, 155.7, 156, 156.8, 157.3, 159, (Csp2). MALDI mass spectrum: [M]-· 960.
1
1-(2,4-Dichlorophenyl)-3-phenylpyrazolo[4',5':1,2]fullerene[60] (5c). H NMR spectrum, δ, ppm
(J, Hz): 7.42 (1H, dd, oJ = 8.47, mJ = 2.36, 5-H); 7.47 (3H, 3-, 4-, 5-HPh); 7.60 (1H, d, mJ = 2.36, 3-HC H Cl ); 7.88
6
3
2
(1H, d, oJ = 8.47, 6-HC H Cl ); 8.23 (2H, d, 2-, 6-HPh). MALDI mass spectrum: [M]-· 983.7.
6
3
2
1
1-(p-Nitrophenyl)-3-(p-nitrophenyl)pyrazolo[4',5':1,2]fullerene[60] (5d). H NMR spectrum, δ, ppm
(J, Hz): 8.31 (2H, d, J = 6.8, 2-, 6-Hp-NO C H ); 8.33 (2H, d, J = 6.8, 3-, 5-Hp-NO C H ); 8.39 (2H, d, J = 9, 2'-,
2
6
4
2 6 4
6'-Hp-NO C H ); 8.62 (2H, d, J = 9, 3'-, 5'-Hp-NO C H ).
2
6
4
2 6 4
3-(p-Ethoxyphenyl)-1-phenylpyrazolo[4',5':1,2]fullerene[60] (5e). 1H NMR spectrum, δ, ppm (J, Hz):
1.46 (3H, t, J = 6.9, CH2CH3); 4.10 (2H, q, J = 6.9, CH2CH3); 6.95 (2H, d, J = 8.6, 3-, 5-Hp-EtOC H ); 7.17, (1H, t,
6
4
4-HPh); 7.40 (2H, t, 3-, 5-HPh); 7.88 (2H, d, 2-, 6-HPh); 8.14 (2H, d, J = 8.6, 2-, 6-Hp-EtOC H ). MALDI mass
6
4
spectrum: [M]-· 958.2.
1-(p-Bromophenyl)-3-(p-ethoxyphenyl)pyrazolo[4',5':1,2]fullerene[60] (5f). 1H NMR spectrum,
δ, ppm (J, Hz): 1.46 (3H, t, J = 6.9, CH2CH3); 4.10 (2H, q, J = 6.9, CH2CH3); 6.96 (2H, d, J = 8.9, 3-,
5-Hp-EtOC H ); 7.52 (2H, d, J = 9, 3-, 5-HPh); 7.84 (2H, d, J = 9, 2-, 6-HPh); 8.14 (2H, d, J = 8.9, 2-, 6-Hp-EtOC H ).
6
4
6 4
MALDI mass spectrum: [M]-· 1038.
1
1-Phenyl-3-trifluoromethylpyrazolo[4',5':1,2]fullerene[60] (5g). H NMR spectrum, δ, ppm: 7.29
(1H, m, 4-HPh); 7.38 (2H, m, 3-, 5-HPh); 7.56 (1H, d, 2-, 6-HPh). MALDI mass spectrum: [M]-· 907.
1-(p-Tolyl)-3-trifluoromethylpyrazolo[4',5':1,2]fullerene[60] (5h). 1H NMR spectrum, δ, ppm (J, Hz):
2.41 (3H, s, CH3); 7.26 (2H, d, J = 8.6, 3-, 5-Hp-CH C H ); 7.69 (2H, d, J = 8.6, 2-, 6-Hp-CH C H ). 13C NMR
3
6
4
3 6 4
spectrum, δ, ppm: 31.7 (CH3); 83.8 (Csp3); 96.3 (Csp3); 129.5 (CF3); group of signals 135-161 (Carom and Cful);
179 (C=N). MALDI mass spectrum: [M]-· 920.7.
1
1-(o-Methoxyphenyl)-3-trifluoromethylpyrazolo[4',5']fullerene[60] (5i). H NMR spectrum, δ, ppm:
3.90 (3H, s, CH3O); 7.06 (2H, m, 3-, 5-Ho-CH OC H ); 7.41 (1H, m, 4-Ho-CH OC H ); 7.65 (1H, m, 6-Ho-CH OC H ).
3
6
4
3
6
4
3
6 4
MALDI mass spectrum: [M-H]-· 935.
192